Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetically Engineered Tobacco Plants Manufacture Antimalaria Drug

By LabMedica International staff writers
Posted on 02 Jan 2012
A line of genetically engineered tobacco plants has been developed that carry all the genes required to encode the entire biochemical pathway necessary for producing the potent, but expensive to produce, antimalarial drug artemisinin.

Artemisinin, a natural compound from Artemisia annua (sweet wormwood) plants, is highly effective against drug-resistant malaria, but low-cost artemisinin-based drugs are lacking because of the high cost of obtaining the natural or chemically synthesized compound.

In seeking a way to produce a low-cost version of artemisinin, investigators at the Hebrew University of Jerusalem (Israel) turned to the tobacco plant. More...
Tobacco has high biomass and grows rapidly, so a suitably modified version would be able to produce large quantities of the drug at low cost.

A recent paper in the December 8, 2011, online edition of the journal Nature Biotechnology reported that such a genetically modified tobacco plant was now available. The authors described the creation of transgenic plants that expressed five plant- and yeast-derived genes involved in the mevalonate and artemisinin pathways, all expressed from a single vector. This study demonstrated that artemisinin can be fully biosynthesized in a heterologous (that is, other than A. annua) plant system. Although the artemisinin levels that were generated in transgenic tobacco were currently lower than those in A. annua, this experimental platform may lead to the design of new routes for the drug's commercial production in heterologous plant systems.

This invention has been patented by Yissum (Jerusalem, Israel), the technology transfer arm of the Hebrew University of Jerusalem, which is now seeking a partner for its further development.

Yaacov Michlin, CEO of Yissum said, “This technology provides, for the first time, the opportunity for manufacturing affordable artemisinin by using tobacco plants. We hope that this invention will eventually help control this prevalent disease, for the benefit of many millions of people around the globe, and in particular in the developing world.”

Related Links:

Hebrew University of Jerusalem
Yissum


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Immunoassay Analyzer
Procise DX
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.